Lin Zhong

Active 1999–2026

464
Papers
22,729
Citations
78
h-index
287
i10-index

Citations

Citations per year for Lin Zhong1993: 1 citations2003: 4 citations2004: 12 citations2005: 24 citations2006: 40 citations2007: 57 citations2008: 65 citations2009: 83 citations2010: 151 citations2011: 229 citations2012: 359 citations2013: 486 citations2014: 634 citations2015: 688 citations2016: 721 citations2017: 718 citations2018: 647 citations2019: 794 citations2020: 1,025 citations2021: 987 citations2022: 842 citations2023: 853 citations2024: 1,310 citations2025: 911 citations2026: 135 citations2027: 2 citations1994–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,535 citing papers, 24.8% of this breakdownUnited States: 3,391 citing papers, 23.8% of this breakdownUnited Kingdom: 719 citing papers, 5% of this breakdownSouth Korea: 531 citing papers, 3.7% of this breakdownGermany: 416 citing papers, 2.9% of this breakdownItaly: 406 citing papers, 2.8% of this breakdownIndia: 357 citing papers, 2.5% of this breakdownJapan: 343 citing papers, 2.4% of this breakdownCanada: 339 citing papers, 2.4% of this breakdownSpain: 305 citing papers, 2.1% of this breakdownFrance: 292 citing papers, 2.1% of this breakdownAustralia: 275 citing papers, 1.9% of this breakdown
0%24.8%Other 23.6%

Fields

  • Computer Science30.8%
  • Engineering22.6%
  • Medicine22.3%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Psychology4.1%
  • Social Sciences1.9%
  • Other8.7%

Topics

  • Green IT and Sustainability3.5%
  • Advanced MIMO Systems Optimization2.2%
  • Lung Cancer Research Studies2.2%
  • Caching and Content Delivery2%
  • Cancer Immunotherapy and Biomarkers1.7%
  • Emotion and Mood Recognition1.5%
  • Other86.9%

Coauthors

All papers

Open in search
  1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sylvia Hartl, Maximilian J. Hochmair, Bernd Lamprecht, Michael Studnicka, Luís Alberto Schlittler, Fabrício Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Baldotto, Cláudia Vaz de Melo Sette, Mauro Zukin, Nikolay Conev, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Xing Li, Zongan Liang, Lin Zhong, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Libor Havel, Vı́tězslav Kolek, Leona Koubková, Jaromı́r Roubec, Jana Skřičková, Milada Zemanová, C. Chouaïd, Werner Hilgers, H. Léna, Denis Moro‐Sibilot, G. Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohé, Eckart Laack, Susanne Lang, Jens Panse, Niels Reinmuth, Christian Schulz and 146 more - The Lancet 2019 cited by 2,199

  2. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Redox Biology 2022 cited by 489

  3. Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lin Wen, Tao Zhang, Hakan Harputluoğlu, İrfan Çiçin, Guosheng Feng, Yanrong Hao, Kejing Ying, Ping Sun, Aihong Zhong, Guangyu An, Yan Wang, Chun Chen, Sheng Yang, Zhendong Chen, Konstantin Penkov, Yuriy Semegen, Oleg Kobziev, Feng Luo, Peiguo Cao, Zhixiong Yang, Min Fan, Wen Li, Robert Mróz, А. Л. Акопов, Tuncay Göksel, Mahmut Gümüş, Wenlei Zhuo, Jian Fang, Hui Zhao, Lin Zhong, Yanping Hu, Yarong Li, Shuqun Zhang, Jiuwei Cui, Н. В. Коваленко, Çağatay Arslan, Devrim Cabuk, Alev Türker, Igor Bondarenko, Yevhen Hotko, O. Goloborodko, Dongji Chen, Mengzhao Wang, Zhuang Yu, Jun‐Guo Lu, Liyan Jiang, Hao Xiong, Davit Giorgadze, Sergey Orlov, Ahmet Bılıcı, Ivan Sinelnikov, Gongyan Chen, Yue Lu, Xiaoli Zhu, Liqin Lu, Mariam Zhvania, Małgorzata Ułańska, Igor Lifirenko, Timur Andabekov, Maria Smagina, Fedor Moiseenko, Yüksel Ürün, Ligong Nie, Bangwei Cao, Zhenyu You, Haixin Huang, Shenpeng Ying, Alexandre Tavartkiladze, Tariel Kitiashvili, Amiran Matitashvili and 9 more - JAMA 2022 cited by 456

  4. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 200

  5. Prompt Cache: Modular Attention Reuse for Low-Latency Inference

    Authors: , , , , , - MLSys 2024 cited by 52

  6. Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury

    Authors: , , , , , , , , , - Stem Cell Research & Therapy 2023 cited by 107

  7. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

    Authors: , , , , , , , , , , , , , - Cancer Immunology Immunotherapy 2017 cited by 294

  8. Drug resistance in ovarian cancer: from mechanism to clinical trial

    Authors: , , , , , , , , , , - Molecular Cancer 2024 cited by 238

  9. Argos: practical many-antenna base stations

    Authors: , , , , , , - conference on Mobile computing and networking, MobiCom 2012 cited by 655

  10. uWave: Accelerometer-based personalized gesture recognition and its applications

    Authors: , , , - Pervasive and Mobile Computing, Pervasive Mob. Comput. 2009 cited by 474

  11. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway

    Authors: , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2016 cited by 375

  12. MIND: In-Network Memory Management for Disaggregated Data Centers

    Authors: , , , , , - SIGOPS 28th Symposium on Operating Systems Principles, SOSP 2021 cited by 52

  13. Future of nanotherapeutics: Targeting the cellular sub-organelles

    Authors: , , , , - Biomaterials 2016 cited by 231

  14. SCFL: Spatio-temporal consistency federated learning for next POI recommendation

    Authors: , , , , - Information Processing & Management, Inf. Process. Manag. 2024 cited by 25

  15. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

    Authors: , , , , , , , , , , , , , , - Journal of the American Heart Association 2021 cited by 93

  16. Agora: Real-time massive MIMO baseband processing in software

    Authors: , , , - Conference on emerging Networking EXperiments and Technologies, CoNEXT 2020 cited by 45

  17. Asynchronous LLM Function Calling

    Authors: , , - arXiv (Cornell University), CoRR 2024 cited by 23

  18. Learning active facial patches for expression analysis

    Authors: , , , , , - IEEE Conference on Computer Vision and Pattern Recognition, CVPR 2012 cited by 374

  19. RedEye

    Authors: , , , , - ACM SIGARCH Computer Architecture News 2016 cited by 195

  20. Rational construction of genome-reduced Burkholderiales chassis facilitates efficient heterologous production of natural products from proteobacteria

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 60

  21. Best-worst individuals driven multiple-layered differential evolution

    Authors: , , , , , - Information Sciences, Inf. Sci. 2023 cited by 34

  22. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016

    Authors: , , , , , , , , , - JAMA Network Open 2020 cited by 84

  23. MoodScope: building a mood sensor from smartphone usage patterns

    Authors: , , , - Proceeding of the 11th annual international conference on Mobile systems, applications, and services, MobiSys 2013 cited by 449

  24. eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 cited by 130